Table 3 Results, in terms of mean value, obtained with GD-EOB-DTPA

Reader 1

GD-EOB-DTPA

 Degree of hyperenhancement of arterial phase

2.7

 Lesion-to-liver contrast during portal phase

4

 Hepatobiliary phase parenchymal hyperenhancement

2,4 for HCC; 2,9 for mCRC with previous chemotherapy; 4 for mCRC without previous chemotherapy

 Quality of arterial phases

2.9

Reader 2

 Degree of hyperenhancement of arterial phase

2.5

 Lesion-to-liver contrast during portal phase

4

 Hepatobiliary phase parenchymal hyperenhancement

2,5 for HCC; 3 for mCRC with previous chemotherapy; 4 for mCRC without previous chemotherapy

 Quality of arterial phases

3

Reader 3

 Degree of hyperenhancement of arterial phase

2.6

 Lesion-to-liver contrast during portal phase

4

 Hepatobiliary phase parenchymal hyperenhancement

2,4 for HCC; 3,3 for mCRC with previous chemotherapy; 4 for mCRC without previous chemotherapy

 Quality of arterial phases

3